Home > Insider Trading > Filing (0000904454-22-000425)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Paratek Pharmaceuticals Inc.	PRTK	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1788249	B. Randall Brenner	C/O Paratek Pharmaceuticals, Inc. 75 Park Plaza, 4Th Floor Boston MA 02116	Chief Development & Regulatory	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-08	47,727	$0.00	368,757	No	4	A	Direct
Common Stock	Disposition	2022-08-09	19,608	$2.66	349,149	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents performance-based restricted stock units ("PRSUs") granted on February 19, 2020 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2022.
Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.58 to $2.78. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.